Document is current
Any future updates will be listed below
-
Authors
Grosch, Markus https://orcid.org/0000-0001-9016-8920
Schraft, Laura https://orcid.org/0009-0005-4504-8926
Chan, Adrian
Küchenhoff, Leonie https://orcid.org/0000-0002-3715-4551
Rapti, Kleopatra
Ferreira, Anne-Maud
Kornienko, Julia https://orcid.org/0000-0002-7876-230X
Li, Shengdi
Radke, Michael H. https://orcid.org/0000-0003-0112-9917
Krämer, Chiara
Clauder-Münster, Sandra
Perlas, Emerald
Backs, Johannes
Gotthardt, Michael https://orcid.org/0000-0003-1788-3172
Dieterich, Christoph https://orcid.org/0000-0001-9468-6311
van den Hoogenhof, Maarten M. G. https://orcid.org/0000-0003-2768-3457
Grimm, Dirk https://orcid.org/0000-0001-6227-5665
Steinmetz, Lars M. https://orcid.org/0000-0002-3962-2865
- License Information
-
More Information
Article History
Received: 13 December 2022
Accepted: 8 June 2023
First Online: 22 June 2023
Competing interests
: The authors Markus Grosch and Lars Steinmetz filed an invention disclose describing the combination of AAV and base editors for treatment of hereditary dilated cardiomyopathy (U.S. Provisional Patent Application No. 63/423,716, status: filed: November 8, 2022). The remaining authors declare no competing interests.
